134 related articles for article (PubMed ID: 27630276)
1. DNA Methylation Machinery in the Endometrium and Endometrial Cancer.
Caplakova V; Babusikova E; Blahovcova E; Balharek T; Zelieskova M; Hatok J
Anticancer Res; 2016 Sep; 36(9):4407-20. PubMed ID: 27630276
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation as mechanism of apoptotic resistance development in endometrial cancer patients.
Fialkova V; Vidomanova E; Balharek T; Marcinek J; Kudela E; Hanysova S; Visnovsky J; Dobrota D; Hatok J
Gen Physiol Biophys; 2017 Dec; 36(5):521-529. PubMed ID: 29372685
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation of endometrium during the menstrual cycle.
Munro SK; Farquhar CM; Mitchell MD; Ponnampalam AP
Mol Hum Reprod; 2010 May; 16(5):297-310. PubMed ID: 20139117
[TBL] [Abstract][Full Text] [Related]
4. Human endometrial DNA methylome is cycle-dependent and is associated with gene expression regulation.
Houshdaran S; Zelenko Z; Irwin JC; Giudice LC
Mol Endocrinol; 2014 Jul; 28(7):1118-35. PubMed ID: 24877562
[TBL] [Abstract][Full Text] [Related]
5. Aberrant Endometrial DNA Methylome and Associated Gene Expression in Women with Endometriosis.
Houshdaran S; Nezhat CR; Vo KC; Zelenko Z; Irwin JC; Giudice LC
Biol Reprod; 2016 Nov; 95(5):93. PubMed ID: 27535958
[TBL] [Abstract][Full Text] [Related]
6. [Estimation of DNA methylation level in endometrial cancer tissues].
Popiela A; Gabryś MS; Rabczyński J; Pańszczyk M; Keith G; Baranowski W
Ginekol Pol; 2002 Nov; 73(11):966-9. PubMed ID: 12722383
[TBL] [Abstract][Full Text] [Related]
7. Carcinogenic mechanisms of endometrial cancer: involvement of genetics and epigenetics.
Banno K; Yanokura M; Iida M; Masuda K; Aoki D
J Obstet Gynaecol Res; 2014 Aug; 40(8):1957-67. PubMed ID: 25131761
[TBL] [Abstract][Full Text] [Related]
8. High frequency of RASSF1A and RARb2 gene promoter methylation in morphologically normal endometrium adjacent to endometrioid adenocarcinoma.
Arafa M; Kridelka F; Mathias V; Vanbellinghen JF; Renard I; Foidart JM; Boniver J; Delvenne P
Histopathology; 2008 Nov; 53(5):525-32. PubMed ID: 18783461
[TBL] [Abstract][Full Text] [Related]
9. Cyclical change of hMSH2 protein expression in normal endometrium during the menstrual cycle and its overexpression in endometrial hyperplasia and sporadic endometrial carcinoma.
Hamid AA; Mandai M; Konishi I; Nanbu K; Tsuruta Y; Kusakari T; Kariya M; Kita M; Fujii S
Cancer; 2002 Feb; 94(4):997-1005. PubMed ID: 11920468
[TBL] [Abstract][Full Text] [Related]
10. The influence of menstrual cycle and endometriosis on endometrial methylome.
Saare M; Modhukur V; Suhorutshenko M; Rajashekar B; Rekker K; Sõritsa D; Karro H; Soplepmann P; Sõritsa A; Lindgren CM; Rahmioglu N; Drong A; Becker CM; Zondervan KT; Salumets A; Peters M
Clin Epigenetics; 2016; 8():2. PubMed ID: 26759613
[TBL] [Abstract][Full Text] [Related]
11. Caspase cascade of Fas-mediated apoptosis in human normal endometrium and endometrial carcinoma cells.
Abe H; Shibata MA; Otsuki Y
Mol Hum Reprod; 2006 Sep; 12(9):535-41. PubMed ID: 16870953
[TBL] [Abstract][Full Text] [Related]
12. The endometrial epigenome and its response to steroid hormones.
Guo SW
Mol Cell Endocrinol; 2012 Jul; 358(2):185-96. PubMed ID: 22067514
[TBL] [Abstract][Full Text] [Related]
13. Importance of promoter methylation of GATA4 and TP53 genes in endometrioid carcinoma of endometrium.
Chmelarova M; Kos S; Dvorakova E; Spacek J; Laco J; Ruszova E; Hrochova K; Palicka V
Clin Chem Lab Med; 2014 Aug; 52(8):1229-34. PubMed ID: 24651021
[TBL] [Abstract][Full Text] [Related]
14. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer.
Sasaki M; Kaneuchi M; Sakuragi N; Dahiya R
Cancer Res; 2003 Jun; 63(12):3101-6. PubMed ID: 12810635
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic DNA hypermethylation: clinical applications in endometrial cancer (Review).
Muraki Y; Banno K; Yanokura M; Kobayashi Y; Kawaguchi M; Nomura H; Hirasawa A; Susumu N; Aoki D
Oncol Rep; 2009 Nov; 22(5):967-72. PubMed ID: 19787208
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma.
Vaskivuo TE; Stenbäck F; Tapanainen JS
Cancer; 2002 Oct; 95(7):1463-71. PubMed ID: 12237915
[TBL] [Abstract][Full Text] [Related]
17. Nuclear localization of beta-catenin in normal and carcinogenic endometrium.
Nei H; Saito T; Yamasaki H; Mizumoto H; Ito E; Kudo R
Mol Carcinog; 1999 Jul; 25(3):207-18. PubMed ID: 10411147
[TBL] [Abstract][Full Text] [Related]
18. Expression of type 2 orexin receptor in human endometrium and its epigenetic silencing in endometrial cancer.
Dehan P; Canon C; Trooskens G; Rehli M; Munaut C; Van Criekinge W; Delvenne P
J Clin Endocrinol Metab; 2013 Apr; 98(4):1549-57. PubMed ID: 23482607
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis in the human uterine endometrium during the menstrual cycle.
Kokawa K; Shikone T; Nakano R
J Clin Endocrinol Metab; 1996 Nov; 81(11):4144-7. PubMed ID: 8923873
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of pro-apoptotic Par-4 by NF-kappaB/p65 and its function in controlling cell kinetics during early events in endometrial tumourigenesis.
Saegusa M; Hashimura M; Kuwata T; Okayasu I
J Pathol; 2010 May; 221(1):26-36. PubMed ID: 20186924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
